drugset / Trial / NCT03006809

Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis

NCT03006809

Phase 1 Completed 30 enrolled Najwa Elnachef
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective unblinded, randomized trial for the use of Fecal Microbiota Transplantation (FMT) for the treatment of Ulcerative Colitis (UC), in combination with or without antibiotic pretreatment.

Timeline

Start
2017-03-02
Primary completion
2020-05-04
Completion
2021-04-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Fecal Microbiota Transplantation (FMT) Other / unclassified Other

Indications